Aceragen, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Aceragen, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q1 2023.
  • Aceragen, Inc. Operating Income (Loss) for the quarter ending March 31, 2023 was -$20.6M, a 393% decline year-over-year.
  • Aceragen, Inc. Operating Income (Loss) for the twelve months ending March 31, 2023 was -$44.2M, a 103% decline year-over-year.
  • Aceragen, Inc. annual Operating Income (Loss) for 2022 was -$27.8M, a 0.52% decline from 2021.
  • Aceragen, Inc. annual Operating Income (Loss) for 2021 was -$27.7M, a 24.6% increase from 2020.
  • Aceragen, Inc. annual Operating Income (Loss) for 2020 was -$36.7M, a 20.4% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$44.2M -$20.6M -$16.4M -393% Jan 1, 2023 Mar 31, 2023 10-Q 2023-06-29
Q4 2022 -$27.8M -$8.94M -$4.82M -117% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-13
Q3 2022 -$23M -$9.33M -$3.36M -56.3% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$19.6M -$5.37M +$2.19M +29% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q1 2022 -$21.8M -$4.18M +$5.85M +58.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-06-29
Q4 2021 -$27.7M -$4.12M +$3.92M +48.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-13
Q3 2021 -$31.6M -$5.97M +$1.52M +20.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$33.1M -$7.56M +$454K +5.67% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$33.6M -$10M +$3.13M +23.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$36.7M -$8.04M +$3.75M +31.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$40.4M -$7.48M +$3.9M +34.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$44.3M -$8.01M +$3.51M +30.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$47.8M -$13.2M -$1.78M -15.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 -$46.1M -$11.8M +$708K +5.67% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-31
Q3 2019 -$46.8M -$11.4M +$493K +4.15% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 -$47.3M -$11.5M +$4.78M +29.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 -$52.1M -$11.4M +$8.9M +43.9% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-02
Q4 2018 -$61M -$12.5M +$2.52M +16.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$63.5M -$11.9M +$2.79M +19% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$66.3M -$16.3M +$5.29M +24.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$71.6M -$20.3M -$5.09M -33.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 -$66.5M -$15M -$15.8M -2122% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 -$50.7M -$14.7M -$1.69M -13% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$49M -$21.6M -$7.99M -58.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 -$41M -$15.2M -$2.27M -17.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$38.8M $743K +$12.8M Oct 1, 2016 Dec 31, 2016 10-K 2019-03-06
Q3 2016 -$51.6M -$13M -$1.51M -13.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 -$50.1M -$13.6M -$829K -6.49% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$49.2M -$12.9M -$395K -3.15% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$48.8M -$12.1M -$154K -1.29% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-07
Q3 2015 -$48.7M -$11.5M -$1.94M -20.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-01
Q2 2015 -$46.7M -$12.8M -$4.45M -53.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-02
Q1 2015 -$42.3M -$12.5M -$3.55M -39.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$38.8M -$11.9M -$5.86M -96.5% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 -$32.9M -$9.52M -$4.84M -103% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$28.1M -$8.33M -$4.76M -134% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$23.3M -$8.97M -$5.13M -133% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$18.2M -$6.07M -$1.74M -40.2% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-10
Q3 2013 -$16.4M -$4.68M +$70K +1.47% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 -$16.5M -$3.57M +$1.76M +33% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$18.3M -$3.85M +$1.65M +29.9% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$19.9M -$4.33M +$2.9M +40.1% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 -$22.8M -$4.75M +$766K +13.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$23.6M -$5.32M +$951K +15.2% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$24.5M -$5.49M +$1.34M +19.6% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$25.9M -$7.23M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-13
Q3 2011 -$5.52M -$628K -12.8% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$6.28M -$916K -17.1% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$6.83M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 -$4.89M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 -$5.36M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.